Global External Pacemaker Market Analysis 2019-2028
External Pacemaker is a form of pacemaker system that is used for cardiac pacing during emergencies caused by cardiac events or over the span of a specified duration as prescribed by the physician. The global external pacemaker market is anticipated to achieve a CAGR of 7.22% during the forecast period, i.e. 2021-2028. Factors such as the consequent entry of products in the market, changing patient awareness regarding the early diagnosis of various chronic disorders, rising disposable income, favorable reimbursement policies and the rising market penetration of key players are anticipated to promote the growth of the global external pacemaker market. Additionally, factors such as growing cases of cardiovascular diseases globally owing to the sedentary lifestyle, eating habits and various eternal factors are anticipated to drive the growth of the global external pacemaker market.
The global external pacemaker market consists of various segments that are segmented by product, device, distribution channel, end user and by region. The market is segmented by device into single chamber, dual chamber and triple chamber. Out of these, the dual chamber segment held the largest market share of around 59% in the year 2018 and is expected to grow at a CAGR of around 8% during the forecast period. Moreover, the segment is also anticipated to reach a value of around USD 1100.00 million by the end of 2028.
Based on region, the global external pacemaker market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market in Asia Pacific, which accounted for around 22% share in the year 2019 is anticipated to grow by a CAGR of around 8% during the forecast period and cross a value of around USD 430 million by the end of 2028.
Some of the affluent industry leaders in the global external pacemaker market are Biotronik SE & Co KG, Medtronic plc, Osypka Medical GmbH, Braile Biomedica, Boston Scientific Corporation, Oscor Inc., Galix Biomedical Instrumentation Inc. and Shree Pacetronix Ltd.
External Pacemaker is a form of pacemaker system that is used for cardiac pacing during emergencies caused by cardiac events or over the span of a specified duration as prescribed by the physician. The global external pacemaker market is anticipated to achieve a CAGR of 7.22% during the forecast period, i.e. 2021-2028. Factors such as the consequent entry of products in the market, changing patient awareness regarding the early diagnosis of various chronic disorders, rising disposable income, favorable reimbursement policies and the rising market penetration of key players are anticipated to promote the growth of the global external pacemaker market. Additionally, factors such as growing cases of cardiovascular diseases globally owing to the sedentary lifestyle, eating habits and various eternal factors are anticipated to drive the growth of the global external pacemaker market.
The global external pacemaker market consists of various segments that are segmented by product, device, distribution channel, end user and by region. The market is segmented by device into single chamber, dual chamber and triple chamber. Out of these, the dual chamber segment held the largest market share of around 59% in the year 2018 and is expected to grow at a CAGR of around 8% during the forecast period. Moreover, the segment is also anticipated to reach a value of around USD 1100.00 million by the end of 2028.
Based on region, the global external pacemaker market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market in Asia Pacific, which accounted for around 22% share in the year 2019 is anticipated to grow by a CAGR of around 8% during the forecast period and cross a value of around USD 430 million by the end of 2028.
Some of the affluent industry leaders in the global external pacemaker market are Biotronik SE & Co KG, Medtronic plc, Osypka Medical GmbH, Braile Biomedica, Boston Scientific Corporation, Oscor Inc., Galix Biomedical Instrumentation Inc. and Shree Pacetronix Ltd.
Table of Contents
Global External Pacemaker Market2. Assumptions and Acronyms3. Research Methodology4. Executive Summary - Global External Pacemaker Market6. Key Market Opportunities8. Impact of COVID-19 on External Pacemaker and Overall Healthcare Industry9. Policy and Regulatory Landscape12. Strategic Recommendations
1. Introduction
5. Market Dynamics
7. OTC Pregnancy Test Kits -Risk Analysis
10. Global External Pacemaker Market Outlook
11. Competitive Structure
Companies Mentioned
- Biotronik SE & Co KG
- Medtronic plc
- Osypka Medical GmbH
- Braile Biomedica
- Boston Scientific Corporation
- Oscor Inc.
- Galix Biomedical Instrumentation Inc.
- Shree Pacetronix Ltd.
